ALG2 is a bifunctional alpha-1,3/alpha-1,6-mannosyltransferase that acts in the early, cytoplasmic phase of dolichol-linked oligosaccharide (LLO) assembly, the glycan-precursor pathway for protein N-glycosylation. Using GDP-mannose as donor, it catalyses the addition of the second and third mannose residues onto Man1GlcNAc2-PP-dolichol to form the branched Man3GlcNAc2-PP-dolichol core, adding one mannose in an alpha-1,3 linkage (EC 2.4.1.132) and one in an alpha-1,6 linkage (EC 2.4.1.257); the Man3GlcNAc2-PP-dolichol product is subsequently elongated by ALG11. It is a member of the GT4 glycosyltransferase family and is anchored to the endoplasmic reticulum membrane with its catalytic domain and active site on the cytoplasmic face. In humans it associates with the ER via a single membrane-binding domain (a topology divergent from the multi-domain yeast ortholog). Loss-of-function variants cause the multisystem congenital disorder of glycosylation type Ii (ALG2-CDG) and an autosomal-recessive congenital myasthenic syndrome (CMS14).
| GO Term | Evidence | Action | Reason |
|---|---|---|---|
|
GO:0012505
endomembrane system
|
IBA
GO_REF:0000033 |
KEEP AS NON CORE |
Summary: Broad endomembrane-system localization inferred phylogenetically. Correct but much less informative than the experimentally supported ER membrane / cytoplasmic side of ER membrane annotations for this enzyme.
Reason: ALG2 is an ER membrane protein, and the ER is part of the endomembrane system, so the term is not wrong. However it is a very general cellular component; the specific ER membrane (GO:0005789) and cytoplasmic side of ER membrane (GO:0098554) annotations, both experimentally supported, capture the localization precisely. Retained as non-core context.
Supporting Evidence:
PMID:35136180
mostly co-localizes with the resident ER membrane protein Calnexin (CANX)
|
|
GO:0000033
alpha-1,3-mannosyltransferase activity
|
IBA
GO_REF:0000033 |
ACCEPT |
Summary: Phylogenetic (IBA) inference of alpha-1,3-mannosyltransferase activity. This is the generic parent of the substrate-specific dolichol-linked activity (GO:0004378) and is well supported for ALG2, which does add an alpha-1,3 mannose.
Reason: ALG2 experimentally adds an alpha-1,3-linked mannose during LLO assembly (PMID:12684507, PMID:35136180). The IBA term is correct; it is broader than the substrate-specific GO:0004378 also annotated here, but is a valid parent-level molecular function and consistent with the phylogenetic evidence.
Supporting Evidence:
PMID:12684507
hALG2 was shown to act as an alpha1,3-mannosyltransferase
|
|
GO:0006488
dolichol-linked oligosaccharide biosynthetic process
|
IBA
GO_REF:0000033 |
ACCEPT |
Summary: Phylogenetic inference that ALG2 participates in dolichol-linked oligosaccharide (LLO) biosynthesis. This is the core biological process for ALG2.
Reason: ALG2 adds the second and third mannoses of the LLO precursor on the cytoplasmic face of the ER (PMID:35136180), and its deficiency blocks LLO elongation with accumulation of Man1/Man2GlcNAc2-PP-dolichol (PMID:12684507). The IBA process annotation is well supported and represents a core function.
Supporting Evidence:
PMID:35136180
Alg2 catalyzes addition of both the second and third mannose to M1Gn2-PDol to form a branched
|
|
GO:0004378
GDP-Man:Man(1)GlcNAc(2)-PP-Dol alpha-1,3-mannosyltransferase activity
|
IEA
GO_REF:0000120 |
ACCEPT |
Summary: Automated (RHEA/EC 2.4.1.132) assignment of the substrate-specific alpha-1,3 mannosyltransferase activity acting on Man1GlcNAc2-PP-dolichol. This is a core molecular function of ALG2 and is duplicated by IDA evidence below.
Reason: The EC/RHEA-based IEA maps exactly onto the experimentally demonstrated alpha-1,3-mannosyltransferase reaction of ALG2 (PMID:12684507, PMID:35136180). Correct and precise; core function.
Supporting Evidence:
PMID:12684507
hALG2 was shown to act as an alpha1,3-mannosyltransferase
|
|
GO:0102704
GDP-Man:Man(2)GlcNAc(2)-PP-Dol alpha-1,6-mannosyltransferase activity
|
IEA
GO_REF:0000120 |
ACCEPT |
Summary: Automated (RHEA/EC 2.4.1.257) assignment of the substrate-specific alpha-1,6 mannosyltransferase activity acting on Man2GlcNAc2-PP-dolichol. This is a core molecular function of ALG2 and is duplicated by IDA evidence below.
Reason: The EC/RHEA-based IEA maps exactly onto the experimentally demonstrated alpha-1,6-mannosyltransferase reaction of ALG2 (PMID:12684507, PMID:35136180). Correct and precise; core function.
Supporting Evidence:
PMID:35136180
Alg2 catalyzes addition of both the second and third mannose to M1Gn2-PDol to form a branched
|
|
GO:0005789
endoplasmic reticulum membrane
|
IEA
GO_REF:0000044 |
ACCEPT |
Summary: Subcellular-location keyword mapping to ER membrane. Consistent with the experimental EXP/IDA localization of ALG2.
Reason: ALG2 localization to the ER membrane is experimentally established by immunofluorescence co-localization with the ER marker Calnexin and by membrane fractionation (PMID:35136180). The IEA CC term is correct and core.
Supporting Evidence:
PMID:35136180
mostly co-localizes with the resident ER membrane protein Calnexin (CANX)
|
|
GO:0009101
glycoprotein biosynthetic process
|
IEA
GO_REF:0000002 |
KEEP AS NON CORE |
Summary: InterPro-to-GO mapping to the broad glycoprotein biosynthetic process. Correct in that ALG2 supplies the N-glycan precursor, but this is a general parent of the more specific LLO biosynthesis / N-linked glycosylation processes.
Reason: ALG2 contributes to glycoprotein biosynthesis via LLO assembly, so the term is not wrong. It is, however, a broad parent term; the specific processes dolichol-linked oligosaccharide biosynthesis (GO:0006488) and protein N-linked glycosylation (GO:0006487), both experimentally supported, better describe the function. Retained as non-core.
Supporting Evidence:
PMID:35136180
N-glycosylation starts with the biosynthesis of lipid-linked oligosaccharide
|
|
GO:0016757
glycosyltransferase activity
|
IEA
GO_REF:0000002 |
KEEP AS NON CORE |
Summary: InterPro-based assignment of the top-level glycosyltransferase activity. Correct but very general; ALG2 is a GT4-family mannosyltransferase.
Reason: ALG2 is a glycosyltransferase (CAZy GT4), so this parent term is accurate but far broader than the substrate-specific mannosyltransferase activities annotated elsewhere (GO:0004378, GO:0102704). Retained as a correct broad parent, non-core.
Supporting Evidence:
PMID:35136180
Alg2 catalyzes addition of both the second and third mannose to M1Gn2-PDol to form a branched
|
|
GO:0005515
protein binding
|
IPI
PMID:32814053 Interactome Mapping Provides a Network of Neurodegenerative ... |
MARK AS OVER ANNOTATED |
Summary: IntAct IPI capturing a yeast two-hybrid interaction between ALG2 and the neurodegeneration protein huntingtin (HTT, P42858) from a neurodegenerative disease interactome screen. Bare "protein binding" is uninformative about ALG2's molecular function.
Reason: The interaction derives from a large-scale Y2H interactome focused on neurodegenerative disease proteins, not from a study of ALG2 function. Per curation guidance, bare "protein binding" is not an informative molecular function and there is no evidence this interaction underlies ALG2's mannosyltransferase role; it is not removed (experimental IPI) but flagged as an over-annotation for the purpose of describing ALG2's core function.
Supporting Evidence:
PMID:32814053
systematic yeast two-hybrid
|
|
GO:0006488
dolichol-linked oligosaccharide biosynthetic process
|
TAS
Reactome:R-HSA-446193 |
ACCEPT |
Summary: Reactome-asserted involvement in LLO (dolichol lipid-linked oligosaccharide) biosynthesis and transfer to nascent protein. Core biological process for ALG2.
Reason: Consistent with the experimental role of ALG2 in adding the second and third mannoses of the LLO precursor (PMID:35136180). Duplicate of the IDA/IBA GO:0006488 annotations; core function.
Supporting Evidence:
PMID:35136180
Alg2 catalyzes addition of both the second and third mannose to M1Gn2-PDol to form a branched
|
|
GO:0005789
endoplasmic reticulum membrane
|
EXP
PMID:35136180 Topological and enzymatic analysis of human Alg2 mannosyltra... |
ACCEPT |
Summary: Experimental (EXP) ER membrane localization from the topological study of human ALG2, based on immunofluorescence co-localization with Calnexin and membrane fractionation.
Reason: Directly demonstrated: FLAG-hAlg2 co-localizes with the ER marker Calnexin and partitions into the ER membrane fraction (PMID:35136180). Core localization.
Supporting Evidence:
PMID:35136180
mostly co-localizes with the resident ER membrane protein Calnexin (CANX)
|
|
GO:0102704
GDP-Man:Man(2)GlcNAc(2)-PP-Dol alpha-1,6-mannosyltransferase activity
|
IDA
PMID:12684507 A new type of congenital disorders of glycosylation (CDG-Ii)... |
ACCEPT |
Summary: Direct assay evidence for the alpha-1,6-mannosyltransferase activity (addition of the third mannose, EC 2.4.1.257). One of the two core catalytic activities of bifunctional ALG2.
Reason: Thiel et al. showed that in ALG2 deficiency both Man1GlcNAc2-PP-dolichol and Man2GlcNAc2-PP-dolichol accumulate, and WT hALG2 restores elongation, implicating ALG2 in the full second-plus-third mannose addition; the bifunctional alpha-1,6 activity is directly confirmed with purified enzyme in PMID:35136180. Core molecular function.
Supporting Evidence:
PMID:12684507
An accumulation of Man1GlcNAc2-PP-dolichol and
PMID:35136180
Alg2 catalyzes addition of both the second and third mannose to M1Gn2-PDol to form a branched
|
|
GO:0004378
GDP-Man:Man(1)GlcNAc(2)-PP-Dol alpha-1,3-mannosyltransferase activity
|
IDA
PMID:12684507 A new type of congenital disorders of glycosylation (CDG-Ii)... |
ACCEPT |
Summary: Direct assay evidence that hALG2 adds the alpha-1,3-linked mannose onto Man1GlcNAc2-PP-dolichol (the second mannose of the LLO, EC 2.4.1.132). One of the two core catalytic activities.
Reason: hALG2 was directly shown to act as an alpha-1,3-mannosyltransferase, producing Manalpha1,3-ManGlcNAc2-PP-dolichol (PMID:12684507), and this substrate-specific activity was confirmed with purified enzyme in PMID:35136180. Core molecular function.
Supporting Evidence:
PMID:12684507
hALG2 was shown to act as an alpha1,3-mannosyltransferase
|
|
GO:0000033
alpha-1,3-mannosyltransferase activity
|
IDA
PMID:35136180 Topological and enzymatic analysis of human Alg2 mannosyltra... |
ACCEPT |
Summary: Direct assay evidence (parent-level term) for alpha-1,3-mannosyltransferase activity from the purified-enzyme kinetic study of human ALG2.
Reason: Purified recombinant hAlg2 transfers an alpha-1,3 mannose onto Man1GlcNAc2-linked substrate (PMID:35136180). Correct; a valid parent of the substrate-specific GO:0004378. Core function (redundant with the more specific term).
Supporting Evidence:
PMID:35136180
Alg2 catalyzes addition of both the second and third mannose to M1Gn2-PDol to form a branched
|
|
GO:0006487
protein N-linked glycosylation
|
IDA
PMID:35136180 Topological and enzymatic analysis of human Alg2 mannosyltra... |
ACCEPT |
Summary: ALG2 acts upstream of and positively affects protein N-linked glycosylation by producing the branched Man3GlcNAc2-PP-dolichol precursor required for building the mature N-glycan that is transferred to protein.
Reason: N-glycosylation begins with LLO biosynthesis, and ALG2 supplies the second and third mannoses of that precursor (PMID:35136180); loss of ALG2 causes CDG with hypoglycosylation, consistent with an upstream positive-regulatory relationship to N-linked glycosylation. Appropriate use of acts_upstream_of_positive_effect.
Supporting Evidence:
PMID:35136180
N-glycosylation starts with the biosynthesis of lipid-linked oligosaccharide
|
|
GO:0006488
dolichol-linked oligosaccharide biosynthetic process
|
IDA
PMID:35136180 Topological and enzymatic analysis of human Alg2 mannosyltra... |
ACCEPT |
Summary: Direct experimental evidence for participation in dolichol-linked oligosaccharide biosynthesis. Core biological process.
Reason: Purified hAlg2 converts Man1GlcNAc2 to the branched Man3GlcNAc2 LLO intermediate (PMID:35136180); this is the defining biological process for ALG2. Core function.
Supporting Evidence:
PMID:35136180
Alg2 catalyzes addition of both the second and third mannose to M1Gn2-PDol to form a branched
|
|
GO:0098554
cytoplasmic side of endoplasmic reticulum membrane
|
IDA
PMID:35136180 Topological and enzymatic analysis of human Alg2 mannosyltra... |
ACCEPT |
Summary: Direct topological evidence that ALG2's active site faces the cytoplasm: both the N- and C-termini (and the catalytic C-terminal domain) are on the cytoplasmic side of the ER membrane.
Reason: Protease-protection (FPP) and Suc2A glycosylation-reporter assays showed both termini of hAlg2 are cytosolic, placing the catalytic domain and its LLO-elongation reaction on the cytoplasmic face of the ER, consistent with the cytosolic phase of LLO assembly (PMID:35136180). Core, precise localization.
Supporting Evidence:
PMID:35136180
both the N- and C-termini of hAlg2 are oriented toward cytoplasmic side of the ER
|
|
GO:0004378
GDP-Man:Man(1)GlcNAc(2)-PP-Dol alpha-1,3-mannosyltransferase activity
|
IDA
PMID:35136180 Topological and enzymatic analysis of human Alg2 mannosyltra... |
ACCEPT |
Summary: Direct assay evidence (substrate-specific, EC 2.4.1.132) for the alpha-1,3 mannosyltransferase activity from the purified-enzyme kinetic study. Core function (duplicate of the PMID:12684507 IDA).
Reason: Kinetic analysis of purified recombinant hAlg2 quantified the alpha-1,3 mannose addition onto Man1GlcNAc2-PP-dolichol (PMID:35136180). Correct and precise; core molecular function.
Supporting Evidence:
PMID:35136180
Alg2 catalyzes addition of both the second and third mannose to M1Gn2-PDol to form a branched
|
|
GO:0102704
GDP-Man:Man(2)GlcNAc(2)-PP-Dol alpha-1,6-mannosyltransferase activity
|
IDA
PMID:35136180 Topological and enzymatic analysis of human Alg2 mannosyltra... |
ACCEPT |
Summary: Direct assay evidence (substrate-specific, EC 2.4.1.257) for the alpha-1,6 mannosyltransferase activity from the purified-enzyme kinetic study. Core function (duplicate of the PMID:12684507 IDA).
Reason: Purified recombinant hAlg2 catalyzes the alpha-1,6 mannose addition producing the branched Man3GlcNAc2-PP-dolichol, with distinct kinetics resolved by an MGAT1-based assay (PMID:35136180). Correct and precise; core molecular function.
Supporting Evidence:
PMID:35136180
Alg2 catalyzes addition of both the second and third mannose to M1Gn2-PDol to form a branched
|
|
GO:0005789
endoplasmic reticulum membrane
|
TAS
Reactome:R-HSA-4549368 |
ACCEPT |
Summary: Reactome-asserted ER membrane localization. Consistent with the experimental localization of ALG2.
Reason: Duplicate of the experimentally supported ER membrane localization (PMID:35136180). Core localization.
Supporting Evidence:
PMID:35136180
mostly co-localizes with the resident ER membrane protein Calnexin (CANX)
|
|
GO:0006488
dolichol-linked oligosaccharide biosynthetic process
|
IGI
PMID:12684507 A new type of congenital disorders of glycosylation (CDG-Ii)... |
ACCEPT |
Summary: Genetic-interaction evidence (with the yeast ALG2 ortholog, P43636) for involvement in LLO biosynthesis: human ALG2 cDNA complements the yeast alg2-1 mutant, restoring dolichol-linked oligosaccharide biosynthesis.
Reason: Cross-species complementation of the yeast alg2-1 mutant by wild-type hALG2 (and failure of mutant hALG2) demonstrated the functional orthology and role in LLO biosynthesis (PMID:12684507). Core process, supported by genetic interaction with P43636.
Supporting Evidence:
PMID:12684507
the yeast ALG2 sequence was used to identify
|
|
GO:0000033
alpha-1,3-mannosyltransferase activity
|
TAS
Reactome:R-HSA-446208 |
ACCEPT |
Summary: Reactome-asserted alpha-1,3-mannosyltransferase activity (addition of a second mannose to the N-glycan precursor by ALG2). Correct parent-level molecular function.
Reason: Consistent with the experimentally demonstrated alpha-1,3-mannosyltransferase activity of ALG2 (PMID:12684507, PMID:35136180). Duplicate of the IDA/IBA GO:0000033 annotations.
Supporting Evidence:
PMID:12684507
hALG2 was shown to act as an alpha1,3-mannosyltransferase
|
|
GO:0000033
alpha-1,3-mannosyltransferase activity
|
TAS
Reactome:R-HSA-4549368 |
ACCEPT |
Summary: Reactome-asserted alpha-1,3-mannosyltransferase activity (from the defective-ALG2 / CDG-1i pathway). Correct parent-level molecular function.
Reason: Consistent with the experimentally demonstrated alpha-1,3-mannosyltransferase activity of ALG2 (PMID:12684507, PMID:35136180). Duplicate of the other GO:0000033 annotations.
Supporting Evidence:
PMID:12684507
hALG2 was shown to act as an alpha1,3-mannosyltransferase
|
|
GO:0009101
glycoprotein biosynthetic process
|
IGI
PMID:12684507 A new type of congenital disorders of glycosylation (CDG-Ii)... |
KEEP AS NON CORE |
Summary: Genetic-interaction (yeast alg2 complementation) evidence mapped to the broad glycoprotein biosynthetic process. Correct but general.
Reason: The yeast complementation experiment (PMID:12684507) supports ALG2's role in glycoprotein biosynthesis, but this is a broad parent of the more specific LLO biosynthesis / N-linked glycosylation processes. Retained as non-core.
Supporting Evidence:
PMID:12684507
the yeast ALG2 sequence was used to identify
|
|
GO:0016020
membrane
|
HDA
PMID:19946888 Defining the membrane proteome of NK cells. |
MARK AS OVER ANNOTATED |
Summary: High-throughput MS detection of ALG2 in a membrane-proteome dataset of an NK-like cell line. Only supports generic "membrane" localization.
Reason: This comes from a large-scale membrane-proteome survey and provides only the uninformative parent term "membrane"; the specific and experimentally supported ER membrane / cytoplasmic side of ER membrane localizations supersede it. Not removed (valid detection) but flagged as an over-annotation for describing ALG2's localization.
Supporting Evidence:
PMID:19946888
identified 1843 proteins with high confidence scores
|
|
GO:0005789
endoplasmic reticulum membrane
|
TAS
Reactome:R-HSA-446208 |
ACCEPT |
Summary: Reactome-asserted ER membrane localization. Consistent with the experimental localization of ALG2.
Reason: Duplicate of the experimentally supported ER membrane localization (PMID:35136180). Core localization.
Supporting Evidence:
PMID:35136180
mostly co-localizes with the resident ER membrane protein Calnexin (CANX)
|
Q: Under physiological GDP-mannose and substrate concentrations in human cells, what is the in vivo balance between the alpha-1,3-first and alpha-1,6-first routes to Man3GlcNAc2-PP-dolichol, and does the M2Gn2(alpha-1,6) intermediate serve any regulatory function?
Q: Does ALG2 function as part of a stable ALG1-ALG2-ALG11 mannosyltransferase complex in human cells, and how does complex assembly affect its bifunctional activity?
Experiment: Reconstitute the human ALG1-ALG2-ALG11 pathway with purified enzymes and defined dolichol-linked substrates to measure channeling and the order of mannose additions in a membrane-mimetic system.
Type: in vitro reconstitution / LC-MS kinetics
Experiment: Structure determination (cryo-EM or crystallography) of human ALG2 in complex with GDP-mannose and a Man1/Man2GlcNAc2-PP-dolichol analog to define the basis of its dual alpha-1,3/alpha-1,6 regioselectivity.
Type: structural biology
ALG2 (alpha-1,3/1,6-mannosyltransferase ALG2) is a bifunctional GDP-mannose:dolichol-linked
oligosaccharide mannosyltransferase acting on the cytoplasmic face of the ER membrane in the
early (cytosolic) phase of N-glycan lipid-linked oligosaccharide (LLO) assembly. It catalyses
addition of the second and third mannose residues onto Man1GlcNAc2-PP-dolichol
(M1Gn2-PDol) to form the branched Man3GlcNAc2-PP-dolichol (M3Gn2-PDol) core, adding one mannose
in an alpha-1,3 linkage and one in an alpha-1,6 linkage. The M3Gn2-PDol product is the substrate
for ALG11 (next enzyme). It is a single-pass / single membrane-binding-domain ER membrane protein
in human (topology differs from yeast). EC 2.4.1.132 (alpha-1,3) and EC 2.4.1.257 (alpha-1,6);
CAZy family GT4 (glycosyltransferase group 1, GT4 subfamily).
Deficiency causes ALG2-CDG (congenital disorder of glycosylation type Ii / CDG-Ii, MIM:607906)
and congenital myasthenic syndrome type 14 (CMS14, MIM:616228).
[PMID:12684507 Thiel et al. 2003 J Biol Chem, "hALG2 was shown to act as an alpha1,3-mannosyltransferase"]
Identified hALG2 as the CDG-Ii gene; deficiency of "GDP-Man:Man1GlcNAc2-PP-dolichol mannosyltransferase (hALG2)";
patient fibroblasts accumulate Man1GlcNAc2-PP-dolichol and Man2GlcNAc2-PP-dolichol; WT hALG2 rescues both patient
fibroblasts and yeast alg2-1. Establishes CDG-Ii, MF (a1,3-MTase), pathway (LLO biosynthesis), and used the yeast
ALG2 (P43636) ortholog for identification (IGI to P43636). Abstract-only in cache.
[PMID:35136180 Xiang et al. 2022 Commun Biol, "Alg2 catalyzes addition of both the second and third mannose to
M1Gn2-PDol to form a branched Man(alpha1,3)Man(alpha1,6)-M1Gn2-PDol (M3Gn2-PDol)"] Full text available.
Purified recombinant hAlg2 shown bifunctional (both a1,3 and a1,6 MTase); ER membrane localization confirmed by
IF (co-localizes with Calnexin) and membrane fractionation; FPP/protease-protection + Suc2A glycosylation-reporter
assays show both N- and C-termini are cytosolic, i.e. the catalytic domain / active site is on the cytoplasmic side
of the ER membrane; single membrane-binding domain in human (vs 4 hydrophobic domains in yeast). Kinetics: prefers
a1,3 then a1,6 route under physiological conditions.
[PMID:23404334 Cossins et al. 2013 Brain] "Congenital myasthenic syndromes due to mutations in ALG2 and ALG14."
Establishes CMS14; variant V68G decreases protein abundance. NOT in publications cache (no annotation cites it in GOA).
[PMID:32814053 Haenig et al. 2020 Cell Rep] Y2H interactome; source of the two IntAct protein-binding IPIs
(ALG2 vs ATXN1 P54253 and HTT P42858). ND-focused interactome; ATXN1 and HTT are neurodegeneration proteins.
Bare protein binding, not an informative MF for ALG2's enzymatic role.
[PMID:19946888 Ghosh et al. 2010 J Mass Spectrom] NK-cell membrane proteome (YTS cell line); source of the HDA
"membrane" localization. Large-scale MS, generic "membrane".
id: Q9H553
gene_symbol: ALG2
product_type: PROTEIN
status: COMPLETE
taxon:
id: NCBITaxon:9606
label: Homo sapiens
description: >-
ALG2 is a bifunctional alpha-1,3/alpha-1,6-mannosyltransferase that acts in the
early, cytoplasmic phase of dolichol-linked oligosaccharide (LLO) assembly, the
glycan-precursor pathway for protein N-glycosylation. Using GDP-mannose as donor,
it catalyses the addition of the second and third mannose residues onto
Man1GlcNAc2-PP-dolichol to form the branched Man3GlcNAc2-PP-dolichol core, adding
one mannose in an alpha-1,3 linkage (EC 2.4.1.132) and one in an alpha-1,6 linkage
(EC 2.4.1.257); the Man3GlcNAc2-PP-dolichol product is subsequently elongated by
ALG11. It is a member of the GT4 glycosyltransferase family and is anchored to the
endoplasmic reticulum membrane with its catalytic domain and active site on the
cytoplasmic face. In humans it associates with the ER via a single membrane-binding
domain (a topology divergent from the multi-domain yeast ortholog). Loss-of-function
variants cause the multisystem congenital disorder of glycosylation type Ii
(ALG2-CDG) and an autosomal-recessive congenital myasthenic syndrome (CMS14).
alternative_products:
- name: '1'
id: Q9H553-1
- name: '2'
id: Q9H553-2
sequence_note: VSP_013188, VSP_013189
existing_annotations:
- term:
id: GO:0012505
label: endomembrane system
evidence_type: IBA
original_reference_id: GO_REF:0000033
qualifier: is_active_in
review:
summary: >-
Broad endomembrane-system localization inferred phylogenetically. Correct but
much less informative than the experimentally supported ER membrane / cytoplasmic
side of ER membrane annotations for this enzyme.
action: KEEP_AS_NON_CORE
reason: >-
ALG2 is an ER membrane protein, and the ER is part of the endomembrane system, so
the term is not wrong. However it is a very general cellular component; the
specific ER membrane (GO:0005789) and cytoplasmic side of ER membrane
(GO:0098554) annotations, both experimentally supported, capture the localization
precisely. Retained as non-core context.
supported_by:
- reference_id: PMID:35136180
supporting_text: mostly co-localizes with the resident ER membrane protein Calnexin (CANX)
- term:
id: GO:0000033
label: alpha-1,3-mannosyltransferase activity
evidence_type: IBA
original_reference_id: GO_REF:0000033
qualifier: enables
review:
summary: >-
Phylogenetic (IBA) inference of alpha-1,3-mannosyltransferase activity. This is
the generic parent of the substrate-specific dolichol-linked activity
(GO:0004378) and is well supported for ALG2, which does add an alpha-1,3 mannose.
action: ACCEPT
reason: >-
ALG2 experimentally adds an alpha-1,3-linked mannose during LLO assembly
(PMID:12684507, PMID:35136180). The IBA term is correct; it is broader than the
substrate-specific GO:0004378 also annotated here, but is a valid parent-level
molecular function and consistent with the phylogenetic evidence.
supported_by:
- reference_id: PMID:12684507
supporting_text: hALG2 was shown to act as an alpha1,3-mannosyltransferase
- term:
id: GO:0006488
label: dolichol-linked oligosaccharide biosynthetic process
evidence_type: IBA
original_reference_id: GO_REF:0000033
qualifier: involved_in
review:
summary: >-
Phylogenetic inference that ALG2 participates in dolichol-linked oligosaccharide
(LLO) biosynthesis. This is the core biological process for ALG2.
action: ACCEPT
reason: >-
ALG2 adds the second and third mannoses of the LLO precursor on the cytoplasmic
face of the ER (PMID:35136180), and its deficiency blocks LLO elongation with
accumulation of Man1/Man2GlcNAc2-PP-dolichol (PMID:12684507). The IBA process
annotation is well supported and represents a core function.
supported_by:
- reference_id: PMID:35136180
supporting_text: Alg2 catalyzes addition of both the second and third mannose to M1Gn2-PDol to form a branched
- term:
id: GO:0004378
label: GDP-Man:Man(1)GlcNAc(2)-PP-Dol alpha-1,3-mannosyltransferase activity
evidence_type: IEA
original_reference_id: GO_REF:0000120
qualifier: enables
review:
summary: >-
Automated (RHEA/EC 2.4.1.132) assignment of the substrate-specific alpha-1,3
mannosyltransferase activity acting on Man1GlcNAc2-PP-dolichol. This is a core
molecular function of ALG2 and is duplicated by IDA evidence below.
action: ACCEPT
reason: >-
The EC/RHEA-based IEA maps exactly onto the experimentally demonstrated
alpha-1,3-mannosyltransferase reaction of ALG2 (PMID:12684507, PMID:35136180).
Correct and precise; core function.
supported_by:
- reference_id: PMID:12684507
supporting_text: hALG2 was shown to act as an alpha1,3-mannosyltransferase
- term:
id: GO:0102704
label: GDP-Man:Man(2)GlcNAc(2)-PP-Dol alpha-1,6-mannosyltransferase activity
evidence_type: IEA
original_reference_id: GO_REF:0000120
qualifier: enables
review:
summary: >-
Automated (RHEA/EC 2.4.1.257) assignment of the substrate-specific alpha-1,6
mannosyltransferase activity acting on Man2GlcNAc2-PP-dolichol. This is a core
molecular function of ALG2 and is duplicated by IDA evidence below.
action: ACCEPT
reason: >-
The EC/RHEA-based IEA maps exactly onto the experimentally demonstrated
alpha-1,6-mannosyltransferase reaction of ALG2 (PMID:12684507, PMID:35136180).
Correct and precise; core function.
supported_by:
- reference_id: PMID:35136180
supporting_text: Alg2 catalyzes addition of both the second and third mannose to M1Gn2-PDol to form a branched
- term:
id: GO:0005789
label: endoplasmic reticulum membrane
evidence_type: IEA
original_reference_id: GO_REF:0000044
qualifier: located_in
review:
summary: >-
Subcellular-location keyword mapping to ER membrane. Consistent with the
experimental EXP/IDA localization of ALG2.
action: ACCEPT
reason: >-
ALG2 localization to the ER membrane is experimentally established by
immunofluorescence co-localization with the ER marker Calnexin and by membrane
fractionation (PMID:35136180). The IEA CC term is correct and core.
supported_by:
- reference_id: PMID:35136180
supporting_text: mostly co-localizes with the resident ER membrane protein Calnexin (CANX)
- term:
id: GO:0009101
label: glycoprotein biosynthetic process
evidence_type: IEA
original_reference_id: GO_REF:0000002
qualifier: involved_in
review:
summary: >-
InterPro-to-GO mapping to the broad glycoprotein biosynthetic process. Correct in
that ALG2 supplies the N-glycan precursor, but this is a general parent of the
more specific LLO biosynthesis / N-linked glycosylation processes.
action: KEEP_AS_NON_CORE
reason: >-
ALG2 contributes to glycoprotein biosynthesis via LLO assembly, so the term is
not wrong. It is, however, a broad parent term; the specific processes
dolichol-linked oligosaccharide biosynthesis (GO:0006488) and protein N-linked
glycosylation (GO:0006487), both experimentally supported, better describe the
function. Retained as non-core.
supported_by:
- reference_id: PMID:35136180
supporting_text: N-glycosylation starts with the biosynthesis of lipid-linked oligosaccharide
- term:
id: GO:0016757
label: glycosyltransferase activity
evidence_type: IEA
original_reference_id: GO_REF:0000002
qualifier: enables
review:
summary: >-
InterPro-based assignment of the top-level glycosyltransferase activity. Correct
but very general; ALG2 is a GT4-family mannosyltransferase.
action: KEEP_AS_NON_CORE
reason: >-
ALG2 is a glycosyltransferase (CAZy GT4), so this parent term is accurate but far
broader than the substrate-specific mannosyltransferase activities annotated
elsewhere (GO:0004378, GO:0102704). Retained as a correct broad parent, non-core.
supported_by:
- reference_id: PMID:35136180
supporting_text: Alg2 catalyzes addition of both the second and third mannose to M1Gn2-PDol to form a branched
- term:
id: GO:0005515
label: protein binding
evidence_type: IPI
original_reference_id: PMID:32814053
qualifier: enables
review:
summary: >-
IntAct IPI capturing a yeast two-hybrid interaction between ALG2 and the
neurodegeneration protein huntingtin (HTT, P42858) from a neurodegenerative
disease interactome screen. Bare "protein binding" is uninformative about ALG2's
molecular function.
action: MARK_AS_OVER_ANNOTATED
reason: >-
The interaction derives from a large-scale Y2H interactome focused on
neurodegenerative disease proteins, not from a study of ALG2 function. Per
curation guidance, bare "protein binding" is not an informative molecular
function and there is no evidence this interaction underlies ALG2's
mannosyltransferase role; it is not removed (experimental IPI) but flagged as an
over-annotation for the purpose of describing ALG2's core function.
supported_by:
- reference_id: PMID:32814053
supporting_text: systematic yeast two-hybrid
- term:
id: GO:0006488
label: dolichol-linked oligosaccharide biosynthetic process
evidence_type: TAS
original_reference_id: Reactome:R-HSA-446193
qualifier: involved_in
review:
summary: >-
Reactome-asserted involvement in LLO (dolichol lipid-linked oligosaccharide)
biosynthesis and transfer to nascent protein. Core biological process for ALG2.
action: ACCEPT
reason: >-
Consistent with the experimental role of ALG2 in adding the second and third
mannoses of the LLO precursor (PMID:35136180). Duplicate of the IDA/IBA
GO:0006488 annotations; core function.
supported_by:
- reference_id: PMID:35136180
supporting_text: Alg2 catalyzes addition of both the second and third mannose to M1Gn2-PDol to form a branched
- term:
id: GO:0005789
label: endoplasmic reticulum membrane
evidence_type: EXP
original_reference_id: PMID:35136180
qualifier: located_in
review:
summary: >-
Experimental (EXP) ER membrane localization from the topological study of human
ALG2, based on immunofluorescence co-localization with Calnexin and membrane
fractionation.
action: ACCEPT
reason: >-
Directly demonstrated: FLAG-hAlg2 co-localizes with the ER marker Calnexin and
partitions into the ER membrane fraction (PMID:35136180). Core localization.
supported_by:
- reference_id: PMID:35136180
supporting_text: mostly co-localizes with the resident ER membrane protein Calnexin (CANX)
- term:
id: GO:0102704
label: GDP-Man:Man(2)GlcNAc(2)-PP-Dol alpha-1,6-mannosyltransferase activity
evidence_type: IDA
original_reference_id: PMID:12684507
qualifier: enables
review:
summary: >-
Direct assay evidence for the alpha-1,6-mannosyltransferase activity (addition of
the third mannose, EC 2.4.1.257). One of the two core catalytic activities of
bifunctional ALG2.
action: ACCEPT
reason: >-
Thiel et al. showed that in ALG2 deficiency both Man1GlcNAc2-PP-dolichol and
Man2GlcNAc2-PP-dolichol accumulate, and WT hALG2 restores elongation, implicating
ALG2 in the full second-plus-third mannose addition; the bifunctional alpha-1,6
activity is directly confirmed with purified enzyme in PMID:35136180. Core
molecular function.
supported_by:
- reference_id: PMID:12684507
supporting_text: An accumulation of Man1GlcNAc2-PP-dolichol and
- reference_id: PMID:35136180
supporting_text: Alg2 catalyzes addition of both the second and third mannose to M1Gn2-PDol to form a branched
- term:
id: GO:0004378
label: GDP-Man:Man(1)GlcNAc(2)-PP-Dol alpha-1,3-mannosyltransferase activity
evidence_type: IDA
original_reference_id: PMID:12684507
qualifier: enables
review:
summary: >-
Direct assay evidence that hALG2 adds the alpha-1,3-linked mannose onto
Man1GlcNAc2-PP-dolichol (the second mannose of the LLO, EC 2.4.1.132). One of the
two core catalytic activities.
action: ACCEPT
reason: >-
hALG2 was directly shown to act as an alpha-1,3-mannosyltransferase, producing
Manalpha1,3-ManGlcNAc2-PP-dolichol (PMID:12684507), and this substrate-specific
activity was confirmed with purified enzyme in PMID:35136180. Core molecular
function.
supported_by:
- reference_id: PMID:12684507
supporting_text: hALG2 was shown to act as an alpha1,3-mannosyltransferase
- term:
id: GO:0000033
label: alpha-1,3-mannosyltransferase activity
evidence_type: IDA
original_reference_id: PMID:35136180
qualifier: enables
review:
summary: >-
Direct assay evidence (parent-level term) for alpha-1,3-mannosyltransferase
activity from the purified-enzyme kinetic study of human ALG2.
action: ACCEPT
reason: >-
Purified recombinant hAlg2 transfers an alpha-1,3 mannose onto Man1GlcNAc2-linked
substrate (PMID:35136180). Correct; a valid parent of the substrate-specific
GO:0004378. Core function (redundant with the more specific term).
supported_by:
- reference_id: PMID:35136180
supporting_text: Alg2 catalyzes addition of both the second and third mannose to M1Gn2-PDol to form a branched
- term:
id: GO:0006487
label: protein N-linked glycosylation
evidence_type: IDA
original_reference_id: PMID:35136180
qualifier: acts_upstream_of_positive_effect
review:
summary: >-
ALG2 acts upstream of and positively affects protein N-linked glycosylation by
producing the branched Man3GlcNAc2-PP-dolichol precursor required for building the
mature N-glycan that is transferred to protein.
action: ACCEPT
reason: >-
N-glycosylation begins with LLO biosynthesis, and ALG2 supplies the second and
third mannoses of that precursor (PMID:35136180); loss of ALG2 causes CDG with
hypoglycosylation, consistent with an upstream positive-regulatory relationship
to N-linked glycosylation. Appropriate use of acts_upstream_of_positive_effect.
supported_by:
- reference_id: PMID:35136180
supporting_text: N-glycosylation starts with the biosynthesis of lipid-linked oligosaccharide
- term:
id: GO:0006488
label: dolichol-linked oligosaccharide biosynthetic process
evidence_type: IDA
original_reference_id: PMID:35136180
qualifier: involved_in
review:
summary: >-
Direct experimental evidence for participation in dolichol-linked oligosaccharide
biosynthesis. Core biological process.
action: ACCEPT
reason: >-
Purified hAlg2 converts Man1GlcNAc2 to the branched Man3GlcNAc2 LLO intermediate
(PMID:35136180); this is the defining biological process for ALG2. Core function.
supported_by:
- reference_id: PMID:35136180
supporting_text: Alg2 catalyzes addition of both the second and third mannose to M1Gn2-PDol to form a branched
- term:
id: GO:0098554
label: cytoplasmic side of endoplasmic reticulum membrane
evidence_type: IDA
original_reference_id: PMID:35136180
qualifier: is_active_in
review:
summary: >-
Direct topological evidence that ALG2's active site faces the cytoplasm: both the
N- and C-termini (and the catalytic C-terminal domain) are on the cytoplasmic
side of the ER membrane.
action: ACCEPT
reason: >-
Protease-protection (FPP) and Suc2A glycosylation-reporter assays showed both
termini of hAlg2 are cytosolic, placing the catalytic domain and its LLO-elongation
reaction on the cytoplasmic face of the ER, consistent with the cytosolic phase of
LLO assembly (PMID:35136180). Core, precise localization.
supported_by:
- reference_id: PMID:35136180
supporting_text: both the N- and C-termini of hAlg2 are oriented toward cytoplasmic side of the ER
- term:
id: GO:0004378
label: GDP-Man:Man(1)GlcNAc(2)-PP-Dol alpha-1,3-mannosyltransferase activity
evidence_type: IDA
original_reference_id: PMID:35136180
qualifier: enables
review:
summary: >-
Direct assay evidence (substrate-specific, EC 2.4.1.132) for the alpha-1,3
mannosyltransferase activity from the purified-enzyme kinetic study. Core function
(duplicate of the PMID:12684507 IDA).
action: ACCEPT
reason: >-
Kinetic analysis of purified recombinant hAlg2 quantified the alpha-1,3 mannose
addition onto Man1GlcNAc2-PP-dolichol (PMID:35136180). Correct and precise; core
molecular function.
supported_by:
- reference_id: PMID:35136180
supporting_text: Alg2 catalyzes addition of both the second and third mannose to M1Gn2-PDol to form a branched
- term:
id: GO:0102704
label: GDP-Man:Man(2)GlcNAc(2)-PP-Dol alpha-1,6-mannosyltransferase activity
evidence_type: IDA
original_reference_id: PMID:35136180
qualifier: enables
review:
summary: >-
Direct assay evidence (substrate-specific, EC 2.4.1.257) for the alpha-1,6
mannosyltransferase activity from the purified-enzyme kinetic study. Core function
(duplicate of the PMID:12684507 IDA).
action: ACCEPT
reason: >-
Purified recombinant hAlg2 catalyzes the alpha-1,6 mannose addition producing the
branched Man3GlcNAc2-PP-dolichol, with distinct kinetics resolved by an MGAT1-based
assay (PMID:35136180). Correct and precise; core molecular function.
supported_by:
- reference_id: PMID:35136180
supporting_text: Alg2 catalyzes addition of both the second and third mannose to M1Gn2-PDol to form a branched
- term:
id: GO:0005789
label: endoplasmic reticulum membrane
evidence_type: TAS
original_reference_id: Reactome:R-HSA-4549368
qualifier: located_in
review:
summary: >-
Reactome-asserted ER membrane localization. Consistent with the experimental
localization of ALG2.
action: ACCEPT
reason: >-
Duplicate of the experimentally supported ER membrane localization
(PMID:35136180). Core localization.
supported_by:
- reference_id: PMID:35136180
supporting_text: mostly co-localizes with the resident ER membrane protein Calnexin (CANX)
- term:
id: GO:0006488
label: dolichol-linked oligosaccharide biosynthetic process
evidence_type: IGI
original_reference_id: PMID:12684507
qualifier: involved_in
review:
summary: >-
Genetic-interaction evidence (with the yeast ALG2 ortholog, P43636) for
involvement in LLO biosynthesis: human ALG2 cDNA complements the yeast alg2-1
mutant, restoring dolichol-linked oligosaccharide biosynthesis.
action: ACCEPT
reason: >-
Cross-species complementation of the yeast alg2-1 mutant by wild-type hALG2 (and
failure of mutant hALG2) demonstrated the functional orthology and role in LLO
biosynthesis (PMID:12684507). Core process, supported by genetic interaction with
P43636.
supported_by:
- reference_id: PMID:12684507
supporting_text: the yeast ALG2 sequence was used to identify
- term:
id: GO:0000033
label: alpha-1,3-mannosyltransferase activity
evidence_type: TAS
original_reference_id: Reactome:R-HSA-446208
qualifier: enables
review:
summary: >-
Reactome-asserted alpha-1,3-mannosyltransferase activity (addition of a second
mannose to the N-glycan precursor by ALG2). Correct parent-level molecular
function.
action: ACCEPT
reason: >-
Consistent with the experimentally demonstrated alpha-1,3-mannosyltransferase
activity of ALG2 (PMID:12684507, PMID:35136180). Duplicate of the IDA/IBA
GO:0000033 annotations.
supported_by:
- reference_id: PMID:12684507
supporting_text: hALG2 was shown to act as an alpha1,3-mannosyltransferase
- term:
id: GO:0000033
label: alpha-1,3-mannosyltransferase activity
evidence_type: TAS
original_reference_id: Reactome:R-HSA-4549368
qualifier: enables
review:
summary: >-
Reactome-asserted alpha-1,3-mannosyltransferase activity (from the defective-ALG2
/ CDG-1i pathway). Correct parent-level molecular function.
action: ACCEPT
reason: >-
Consistent with the experimentally demonstrated alpha-1,3-mannosyltransferase
activity of ALG2 (PMID:12684507, PMID:35136180). Duplicate of the other GO:0000033
annotations.
supported_by:
- reference_id: PMID:12684507
supporting_text: hALG2 was shown to act as an alpha1,3-mannosyltransferase
- term:
id: GO:0009101
label: glycoprotein biosynthetic process
evidence_type: IGI
original_reference_id: PMID:12684507
qualifier: involved_in
review:
summary: >-
Genetic-interaction (yeast alg2 complementation) evidence mapped to the broad
glycoprotein biosynthetic process. Correct but general.
action: KEEP_AS_NON_CORE
reason: >-
The yeast complementation experiment (PMID:12684507) supports ALG2's role in
glycoprotein biosynthesis, but this is a broad parent of the more specific LLO
biosynthesis / N-linked glycosylation processes. Retained as non-core.
supported_by:
- reference_id: PMID:12684507
supporting_text: the yeast ALG2 sequence was used to identify
- term:
id: GO:0016020
label: membrane
evidence_type: HDA
original_reference_id: PMID:19946888
qualifier: located_in
review:
summary: >-
High-throughput MS detection of ALG2 in a membrane-proteome dataset of an NK-like
cell line. Only supports generic "membrane" localization.
action: MARK_AS_OVER_ANNOTATED
reason: >-
This comes from a large-scale membrane-proteome survey and provides only the
uninformative parent term "membrane"; the specific and experimentally supported ER
membrane / cytoplasmic side of ER membrane localizations supersede it. Not removed
(valid detection) but flagged as an over-annotation for describing ALG2's
localization.
supported_by:
- reference_id: PMID:19946888
supporting_text: identified 1843 proteins with high confidence scores
- term:
id: GO:0005789
label: endoplasmic reticulum membrane
evidence_type: TAS
original_reference_id: Reactome:R-HSA-446208
qualifier: located_in
review:
summary: >-
Reactome-asserted ER membrane localization. Consistent with the experimental
localization of ALG2.
action: ACCEPT
reason: >-
Duplicate of the experimentally supported ER membrane localization
(PMID:35136180). Core localization.
supported_by:
- reference_id: PMID:35136180
supporting_text: mostly co-localizes with the resident ER membrane protein Calnexin (CANX)
core_functions:
- description: >-
Adds the second mannose of the LLO precursor in an alpha-1,3 linkage: transfers
mannose from GDP-mannose onto Man1GlcNAc2-PP-dolichol to form
Man(alpha1,3)Man1GlcNAc2-PP-dolichol (EC 2.4.1.132), on the cytoplasmic face of the
ER membrane during dolichol-linked oligosaccharide biosynthesis.
molecular_function:
id: GO:0004378
label: GDP-Man:Man(1)GlcNAc(2)-PP-Dol alpha-1,3-mannosyltransferase activity
directly_involved_in:
- id: GO:0006488
label: dolichol-linked oligosaccharide biosynthetic process
locations:
- id: GO:0005789
label: endoplasmic reticulum membrane
- id: GO:0098554
label: cytoplasmic side of endoplasmic reticulum membrane
supported_by:
- reference_id: PMID:12684507
supporting_text: hALG2 was shown to act as an alpha1,3-mannosyltransferase
- reference_id: PMID:35136180
supporting_text: Alg2 catalyzes addition of both the second and third mannose to M1Gn2-PDol to form a branched
- description: >-
Adds the third mannose of the LLO precursor in an alpha-1,6 linkage: transfers
mannose from GDP-mannose onto Man2GlcNAc2-PP-dolichol to complete the branched
Man3GlcNAc2-PP-dolichol core (EC 2.4.1.257), on the cytoplasmic face of the ER
membrane. This branched product is the substrate for ALG11.
molecular_function:
id: GO:0102704
label: GDP-Man:Man(2)GlcNAc(2)-PP-Dol alpha-1,6-mannosyltransferase activity
directly_involved_in:
- id: GO:0006488
label: dolichol-linked oligosaccharide biosynthetic process
locations:
- id: GO:0005789
label: endoplasmic reticulum membrane
- id: GO:0098554
label: cytoplasmic side of endoplasmic reticulum membrane
supported_by:
- reference_id: PMID:35136180
supporting_text: Alg2 catalyzes addition of both the second and third mannose to M1Gn2-PDol to form a branched
- description: >-
Through LLO biosynthesis, ALG2 acts upstream of protein N-linked glycosylation,
providing the mannosylated dolichol-linked oligosaccharide precursor that is
ultimately transferred to asparagine residues of nascent glycoproteins.
molecular_function:
id: GO:0004378
label: GDP-Man:Man(1)GlcNAc(2)-PP-Dol alpha-1,3-mannosyltransferase activity
directly_involved_in:
- id: GO:0006487
label: protein N-linked glycosylation
locations:
- id: GO:0005789
label: endoplasmic reticulum membrane
supported_by:
- reference_id: PMID:35136180
supporting_text: N-glycosylation starts with the biosynthesis of lipid-linked oligosaccharide
references:
- id: GO_REF:0000002
title: Gene Ontology annotation through association of InterPro records with GO
terms
findings: []
- id: GO_REF:0000033
title: Annotation inferences using phylogenetic trees
findings: []
- id: GO_REF:0000044
title: Gene Ontology annotation based on UniProtKB/Swiss-Prot Subcellular Location
vocabulary mapping, accompanied by conservative changes to GO terms applied by
UniProt
findings: []
- id: GO_REF:0000120
title: Combined Automated Annotation using Multiple IEA Methods
findings: []
- id: PMID:12684507
title: A new type of congenital disorders of glycosylation (CDG-Ii) provides new
insights into the early steps of dolichol-linked oligosaccharide biosynthesis.
findings:
- statement: >-
Identified human ALG2 as the gene deficient in CDG-Ii; patient fibroblasts
accumulate Man1GlcNAc2-PP-dolichol and Man2GlcNAc2-PP-dolichol, and hALG2 acts as
an alpha-1,3-mannosyltransferase in dolichol-linked oligosaccharide biosynthesis.
supporting_text: hALG2 was shown to act as an alpha1,3-mannosyltransferase
reference_review:
relevance: HIGH
correctness: VERIFIED
review_notes: >-
PubMed-verified. Abstract-only in cache; establishes ALG2 = CDG-Ii gene, the
alpha-1,3-mannosyltransferase activity, the LLO biosynthesis process, and the
yeast-complementation genetic interaction (IGI to P43636).
- id: PMID:19946888
title: Defining the membrane proteome of NK cells.
findings:
- statement: >-
Large-scale membrane-proteome MS study of an NK-like cell line that detected ALG2
among membrane-associated proteins, supporting only a generic membrane
localization.
supporting_text: identified 1843 proteins with high confidence scores
reference_review:
relevance: LOW
correctness: VERIFIED
review_notes: >-
Abstract-only in cache. High-throughput proteomics; provides only broad "membrane"
CC evidence, superseded by ER membrane localization.
- id: PMID:32814053
title: Interactome Mapping Provides a Network of Neurodegenerative Disease Proteins
and Uncovers Widespread Protein Aggregation in Affected Brains.
findings:
- statement: >-
Systematic yeast two-hybrid interactome of neurodegenerative disease proteins that
is the source of the ALG2 IntAct protein-binding interactions (with ATXN1 and HTT);
not a study of ALG2 enzymatic function.
supporting_text: systematic yeast two-hybrid
reference_review:
relevance: LOW
correctness: VERIFIED
review_notes: >-
Abstract-only in cache. Source of bare "protein binding" IPIs; interactions are
from a ND-focused Y2H screen and do not inform ALG2's mannosyltransferase function.
- id: PMID:35136180
title: Topological and enzymatic analysis of human Alg2 mannosyltransferase reveals
its role in lipid-linked oligosaccharide biosynthetic pathway.
findings:
- statement: >-
Human ALG2 is a bifunctional alpha-1,3/alpha-1,6-mannosyltransferase that adds the
second and third mannoses to Man1GlcNAc2-PP-dolichol to form branched
Man3GlcNAc2-PP-dolichol.
supporting_text: Alg2 catalyzes addition of both the second and third mannose to M1Gn2-PDol to form a branched
- statement: >-
ALG2 localizes to the ER membrane (co-localizes with Calnexin) and both its termini
and catalytic domain face the cytoplasm; in human it uses a single membrane-binding
domain.
supporting_text: both the N- and C-termini of hAlg2 are oriented toward cytoplasmic side of the ER
reference_review:
relevance: HIGH
correctness: VERIFIED
review_notes: >-
Full text available (PMC8827073). Definitive source for the bifunctional MF terms,
ER membrane localization, and cytoplasmic-side topology of human ALG2.
- id: Reactome:R-HSA-446193
title: Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide,
LLO) and transfer to a nascent protein
findings: []
- id: Reactome:R-HSA-446208
title: Addition of a second mannose to the N-glycan precursor by ALG2
findings: []
- id: Reactome:R-HSA-4549368
title: Defective ALG2 does not transfer a second Man to N-glycan precursor
findings: []
suggested_questions:
- question: >-
Under physiological GDP-mannose and substrate concentrations in human cells, what is
the in vivo balance between the alpha-1,3-first and alpha-1,6-first routes to
Man3GlcNAc2-PP-dolichol, and does the M2Gn2(alpha-1,6) intermediate serve any
regulatory function?
- question: >-
Does ALG2 function as part of a stable ALG1-ALG2-ALG11 mannosyltransferase complex
in human cells, and how does complex assembly affect its bifunctional activity?
suggested_experiments:
- description: >-
Reconstitute the human ALG1-ALG2-ALG11 pathway with purified enzymes and defined
dolichol-linked substrates to measure channeling and the order of mannose additions
in a membrane-mimetic system.
experiment_type: in vitro reconstitution / LC-MS kinetics
- description: >-
Structure determination (cryo-EM or crystallography) of human ALG2 in complex with
GDP-mannose and a Man1/Man2GlcNAc2-PP-dolichol analog to define the basis of its dual
alpha-1,3/alpha-1,6 regioselectivity.
experiment_type: structural biology